COVIVIO HOTELS SACA (COVH.PA) Fundamental Analysis & Valuation

EPA:COVH • FR0000060303

Current stock price

23.5 EUR
+0.1 (+0.43%)
Last:

This COVH.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. COVH.PA Profitability Analysis

1.1 Basic Checks

  • In the past year COVH was profitable.
  • COVH had a positive operating cash flow in the past year.
  • COVH had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years COVH had a positive operating cash flow.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • The Return On Assets of COVH (4.53%) is better than 68.29% of its industry peers.
  • COVH has a Return On Equity of 8.34%. This is in the better half of the industry: COVH outperforms 68.29% of its industry peers.
  • COVH has a Return On Invested Capital of 3.47%. This is comparable to the rest of the industry: COVH outperforms 53.66% of its industry peers.
  • COVH had an Average Return On Invested Capital over the past 3 years of 3.84%. This is in line with the industry average of 3.75%.
Industry RankSector Rank
ROA 4.53%
ROE 8.34%
ROIC 3.47%
ROA(3y)2.5%
ROA(5y)3.01%
ROE(3y)4.84%
ROE(5y)5.9%
ROIC(3y)3.84%
ROIC(5y)3.38%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • COVH has a Profit Margin of 43.94%. This is comparable to the rest of the industry: COVH outperforms 48.78% of its industry peers.
  • COVH's Profit Margin has declined in the last couple of years.
  • COVH has a worse Operating Margin (36.53%) than 70.73% of its industry peers.
  • In the last couple of years the Operating Margin of COVH has declined.
  • With a Gross Margin value of 52.00%, COVH is not doing good in the industry: 70.73% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of COVH has grown nicely.
Industry RankSector Rank
OM 36.53%
PM (TTM) 43.94%
GM 52%
OM growth 3Y-30.11%
OM growth 5Y-7.29%
PM growth 3Y-39.31%
PM growth 5YN/A
GM growth 3Y15.72%
GM growth 5Y8.73%
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. COVH.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COVH is destroying value.
  • The number of shares outstanding for COVH has been increased compared to 1 year ago.
  • COVH has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for COVH has been reduced compared to a year ago.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.27, we must say that COVH is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.27, COVH is in the better half of the industry, outperforming 78.05% of the companies in the same industry.
  • COVH has a debt to FCF ratio of 9.89. This is a negative value and a sign of low solvency as COVH would need 9.89 years to pay back of all of its debts.
  • COVH has a Debt to FCF ratio of 9.89. This is amongst the best in the industry. COVH outperforms 80.49% of its industry peers.
  • A Debt/Equity ratio of 0.67 indicates that COVH is somewhat dependend on debt financing.
  • COVH has a Debt to Equity ratio of 0.67. This is comparable to the rest of the industry: COVH outperforms 56.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 9.89
Altman-Z 1.27
ROIC/WACC0.64
WACC5.38%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • COVH has a Current Ratio of 1.81. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
  • COVH's Current ratio of 1.81 is amongst the best of the industry. COVH outperforms 95.12% of its industry peers.
  • A Quick Ratio of 1.80 indicates that COVH should not have too much problems paying its short term obligations.
  • COVH's Quick ratio of 1.80 is amongst the best of the industry. COVH outperforms 95.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.8
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. COVH.PA Growth Analysis

3.1 Past

  • COVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.73%, which is quite impressive.
  • The earnings per share for COVH have been decreasing by -14.88% on average. This is quite bad
  • COVH shows a strong growth in Revenue. In the last year, the Revenue has grown by 53.70%.
  • Measured over the past years, COVH shows a very strong growth in Revenue. The Revenue has been growing by 35.44% on average per year.
EPS 1Y (TTM)30.73%
EPS 3Y-14.88%
EPS 5YN/A
EPS Q2Q%98.41%
Revenue 1Y (TTM)53.7%
Revenue growth 3Y42.19%
Revenue growth 5Y35.44%
Sales Q2Q%12.3%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. COVH.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.87, the valuation of COVH can be described as reasonable.
  • Based on the Price/Earnings ratio, COVH is valued a bit cheaper than 63.41% of the companies in the same industry.
  • COVH is valuated cheaply when we compare the Price/Earnings ratio to 27.89, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 13.63, COVH is valued correctly.
  • COVH's Price/Forward Earnings is on the same level as the industry average.
  • COVH is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.87
Fwd PE 13.63
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • COVH's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as COVH.
Industry RankSector Rank
P/FCF 14.4
EV/EBITDA 17.48
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. COVH.PA Dividend Analysis

5.1 Amount

  • COVH has a Yearly Dividend Yield of 6.17%, which is a nice return.
  • Compared to an average industry Dividend Yield of 5.38, COVH pays a bit more dividend than its industry peers.
  • COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.17%

5.2 History

  • The dividend of COVH is nicely growing with an annual growth rate of 64.76%!
Dividend Growth(5Y)64.76%
Div Incr Years4
Div Non Decr Years5
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • COVH pays out 12.80% of its income as dividend. This is a sustainable payout ratio.
DP12.8%
EPS Next 2YN/A
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COVH.PA Fundamentals: All Metrics, Ratios and Statistics

COVIVIO HOTELS SACA

EPA:COVH (4/20/2026, 12:52:03 PM)

23.5

+0.1 (+0.43%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18
Earnings (Next)07-21
Inst Owners31.73%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.71B
Revenue(TTM)700.20M
Net Income(TTM)307.70M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.17%
Yearly Dividend0.26
Dividend Growth(5Y)64.76%
DP12.8%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.87
Fwd PE 13.63
P/S 5.3
P/FCF 14.4
P/OCF 11.93
P/B 1.01
P/tB 1.1
EV/EBITDA 17.48
EPS(TTM)1.98
EY8.43%
EPS(NY)1.72
Fwd EY7.34%
FCF(TTM)1.63
FCFY6.94%
OCF(TTM)1.97
OCFY8.38%
SpS4.43
BVpS23.36
TBVpS21.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.263 (37.29%)
Profitability
Industry RankSector Rank
ROA 4.53%
ROE 8.34%
ROCE 3.92%
ROIC 3.47%
ROICexc 3.51%
ROICexgc 3.69%
OM 36.53%
PM (TTM) 43.94%
GM 52%
FCFM 36.82%
ROA(3y)2.5%
ROA(5y)3.01%
ROE(3y)4.84%
ROE(5y)5.9%
ROIC(3y)3.84%
ROIC(5y)3.38%
ROICexc(3y)4.06%
ROICexc(5y)3.53%
ROICexgc(3y)4.24%
ROICexgc(5y)3.66%
ROCE(3y)4.33%
ROCE(5y)3.81%
ROICexgc growth 3Y1.88%
ROICexgc growth 5Y26.81%
ROICexc growth 3Y0.7%
ROICexc growth 5Y25.99%
OM growth 3Y-30.11%
OM growth 5Y-7.29%
PM growth 3Y-39.31%
PM growth 5YN/A
GM growth 3Y15.72%
GM growth 5Y8.73%
F-Score7
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 9.89
Debt/EBITDA 6.96
Cap/Depr 54.77%
Cap/Sales 7.63%
Interest Coverage 4.26
Cash Conversion 88.08%
Profit Quality 83.78%
Current Ratio 1.81
Quick Ratio 1.8
Altman-Z 1.27
F-Score7
WACC5.38%
ROIC/WACC0.64
Cap/Depr(3y)125.87%
Cap/Depr(5y)134.29%
Cap/Sales(3y)12.4%
Cap/Sales(5y)21.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.73%
EPS 3Y-14.88%
EPS 5YN/A
EPS Q2Q%98.41%
EPS Next Y-1.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)53.7%
Revenue growth 3Y42.19%
Revenue growth 5Y35.44%
Sales Q2Q%12.3%
Revenue Next Year2.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.12%
EBIT growth 3Y-0.62%
EBIT growth 5Y25.57%
EBIT Next Year-5.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.09%
FCF growth 3Y11.53%
FCF growth 5Y55.72%
OCF growth 1Y-10.63%
OCF growth 3Y6.6%
OCF growth 5Y31.01%

COVIVIO HOTELS SACA / COVH.PA Fundamental Analysis FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 5 / 10 to COVH.PA.


What is the valuation status for COVH stock?

ChartMill assigns a valuation rating of 4 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for COVIVIO HOTELS SACA?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 4 / 10.


What is the valuation of COVIVIO HOTELS SACA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for COVIVIO HOTELS SACA (COVH.PA) is 11.87 and the Price/Book (PB) ratio is 1.01.


Can you provide the dividend sustainability for COVH stock?

The dividend rating of COVIVIO HOTELS SACA (COVH.PA) is 7 / 10 and the dividend payout ratio is 12.8%.